Tania Armstrong-Whitworth
Stock Analyst at Canaccord Genuity
(3.69)
# 2,132
Out of 4,649 analysts
150
Total ratings
44.7%
Success rate
6.2%
Average return
Main Sectors:
Stocks Rated by Tania Armstrong-Whitworth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: JWEL Jamieson Wellness Inc. | Downgraded: Hold | $43.50 → $45.75 | $45.61 | +0.31% | 17 | Aug 10, 2026 | |
| TSX: APTX Apotex Health Corp. | Initiated Coverage: Buy | $42.00 | $34.15 | +22.99% | 1 | Jul 13, 2026 | |
| TSXV: DMGI DMG Blockchain Solutions Inc. | Initiated Coverage: Buy | $0.50 → $0.40 | $0.49 | -18.37% | 4 | May 27, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Initiated Coverage: Buy | $1.25 → $19.00 | $13.38 | +42.00% | 5 | May 21, 2026 | |
| TSX: HLS HLS Therapeutics Inc. | Initiated Coverage: Hold | $4.00 → $5.00 | $3.90 | +28.21% | 20 | May 19, 2026 | |
| TSX: GUD Knight Therapeutics Inc. | Initiated Coverage: Buy | $7.50 → $9.50 | $9.32 | +1.93% | 23 | May 8, 2026 | |
| TSX: EXE Extendicare Inc. | Maintained: Buy | $13.00 → $22.50 | $32.74 | -31.28% | 2 | Dec 4, 2025 | |
| TSXV: BTCT Bitcoin Treasury Corporation | Maintained: Buy | $13.50 → $12.25 | $3.14 | +290.13% | 3 | Nov 14, 2025 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Maintained: Buy | $9.00 | $9.31 | -3.33% | 5 | Sep 2, 2025 | |
| TSX: CPH Cipher Pharmaceuticals Inc. | Maintained: Hold | $13.00 → $14.00 | $14.14 | n/a | 4 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18.00 → $19.50 | $18.25 | n/a | 4 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.25 → $3.50 | $3.25 | n/a | 8 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.00 → $2.65 | $5.34 | n/a | 18 | Jul 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.4 → $0.32 | $0.0942 | n/a | 10 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $18 | $42.63 | n/a | 12 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Buy | $3.50 → $3.00 | $2.00 | n/a | 14 | Jun 28, 2022 |
Jamieson Wellness Inc.
Aug 10, 2026
Downgraded: Hold
Price Target: $43.50 → $45.75
Current: $45.61
Upside: +0.31%
Apotex Health Corp.
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $42.00
Current: $34.15
Upside: +22.99%
DMG Blockchain Solutions Inc.
May 27, 2026
Initiated Coverage: Buy
Price Target: $0.50 → $0.40
Current: $0.49
Upside: -18.37%
Satellos Bioscience Inc.
May 21, 2026
Initiated Coverage: Buy
Price Target: $1.25 → $19.00
Current: $13.38
Upside: +42.00%
HLS Therapeutics Inc.
May 19, 2026
Initiated Coverage: Hold
Price Target: $4.00 → $5.00
Current: $3.90
Upside: +28.21%
Knight Therapeutics Inc.
May 8, 2026
Initiated Coverage: Buy
Price Target: $7.50 → $9.50
Current: $9.32
Upside: +1.93%
Extendicare Inc.
Dec 4, 2025
Maintained: Buy
Price Target: $13.00 → $22.50
Current: $32.74
Upside: -31.28%
Bitcoin Treasury Corporation
Nov 14, 2025
Maintained: Buy
Price Target: $13.50 → $12.25
Current: $3.14
Upside: +290.13%
Eupraxia Pharmaceuticals Inc.
Sep 2, 2025
Maintained: Buy
Price Target: $9.00
Current: $9.31
Upside: -3.33%
Cipher Pharmaceuticals Inc.
Aug 11, 2025
Maintained: Hold
Price Target: $13.00 → $14.00
Current: $14.14
Upside: n/a
Nov 5, 2024
Maintained: Buy
Price Target: $18.00 → $19.50
Current: $18.25
Upside: n/a
Aug 8, 2024
Maintained: Buy
Price Target: $4.25 → $3.50
Current: $3.25
Upside: n/a
Jul 4, 2024
Maintained: Buy
Price Target: $3.00 → $2.65
Current: $5.34
Upside: n/a
Nov 15, 2023
Maintained: Hold
Price Target: $0.4 → $0.32
Current: $0.0942
Upside: n/a
Nov 21, 2022
Maintained: Buy
Price Target: $22 → $18
Current: $42.63
Upside: n/a
Jun 28, 2022
Downgraded: Buy
Price Target: $3.50 → $3.00
Current: $2.00
Upside: n/a